| P50 | author | Maria J Redondo | Q56974753 |
| | Omaima M Sabek | Q57058157 |
| | Duc T Nguyen | Q88370692 |
| | Edward A Graviss | Q88370694 |
| | Christine A Beamish | Q92544151 |
| P2093 | author name string | Christiane S Hampe | |
| | A Osama Gaber | |
| | Daniel W Fraga | |
| | Surya N Mulukutla | |
| P2860 | cites work | Endocrine regulation of energy metabolism by the skeleton | Q22337453 |
| | The honeymoon phase: intersection of metabolism and immunology | Q28247818 |
| | GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo | Q28307776 |
| | Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone | Q28646319 |
| | CDC growth charts: United States | Q29615833 |
| | Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome | Q33569709 |
| | Carboxylation of osteocalcin affects its association with metabolic parameters in healthy children | Q33683813 |
| | Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. | Q33736145 |
| | Undercarboxylated osteocalcin can predict insulin secretion ability in type 2 diabetes | Q33871350 |
| | Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism | Q34021680 |
| | Epidemiology of type 1 diabetes | Q34078199 |
| | Beta-cell adaptation and decompensation during the progression of diabetes. | Q34197338 |
| | The effectiveness and durability of an early insulin pump therapy in children and adolescents with type 1 diabetes mellitus | Q34360873 |
| | Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study | Q34448739 |
| | Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline | Q34571784 |
| | Delayed skeletal muscle mitochondrial ADP recovery in youth with type 1 diabetes relates to muscle insulin resistance | Q35004291 |
| | Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. | Q35203692 |
| | Serum adiposity-induced biomarkers in obese and lean children with recently diagnosed autoimmune type 1 diabetes | Q35581618 |
| | Osteocalcin Effect on Human β-Cells Mass and Function | Q35685113 |
| | Relationship between beta-cell mass and diabetes onset. | Q36034329 |
| | Determinants of undercarboxylated and carboxylated osteocalcin concentrations in type 1 diabetes | Q36317621 |
| | β-cell mass and turnover in humans: effects of obesity and aging | Q36477911 |
| | The lack of anti-idiotypic antibodies, not the presence of the corresponding autoantibodies to glutamate decarboxylase, defines type 1 diabetes | Q36535592 |
| | Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans | Q36971500 |
| | Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and β-cell function in overweight adults | Q36982011 |
| | New definition for the partial remission period in children and adolescents with type 1 diabetes | Q37269446 |
| | Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis | Q37381466 |
| | ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset | Q37520312 |
| | Osteocalcin promotes β-cell proliferation during development and adulthood through Gprc6a | Q37597067 |
| | Use of insulin in type 2 diabetes: what we learned from recent clinical trials on the benefits of early insulin initiation | Q38275818 |
| | Serum undercarboxylated osteocalcin correlates with hemoglobin A1c in children with recently diagnosed pediatric diabetes. | Q39017503 |
| | Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes | Q39626208 |
| | DPD epitope-specific glutamic acid decarboxylase (GAD)65 autoantibodies in children with Type 1 diabetes | Q40070247 |
| | C-peptide levels in pediatric type 2 diabetes in the Pediatric Diabetes Consortium T2D Clinic Registry | Q40976863 |
| | Role of reduced β-cell mass versus impaired β-cell function in the pathogenesis of type 2 diabetes | Q41945969 |
| | Diabetes Antibody Standardization Program: First Assay Proficiency Evaluation | Q44418700 |
| | Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus | Q46264486 |
| | Pancreatic beta-cell mass in European subjects with type 2 diabetes | Q46332814 |
| | Beta cell function and BMI in ethnically diverse children with newly diagnosed autoimmune type 1 diabetes | Q46878505 |
| | C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. | Q47299422 |
| | Relationship of Serum Fetuin A with Metabolic and Clinical Parameters in German Children and Adolescents with Type 1 Diabetes | Q47365110 |
| | Insulin and osteocalcin: further evidence for a mutual cross-talk. | Q48135687 |
| | α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes. | Q50420512 |
| | Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999. | Q50787251 |
| | Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes. | Q51383721 |
| | The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. | Q51439207 |
| | Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population | Q58594757 |
| | Proinsulin, GLP-1, and glucagon are associated with partial remission in children and adolescents with newly diagnosed type 1 diabetes | Q59487901 |
| | Circulating osteocalcin as a bone-derived hormone is inversely correlated with body fat in patients with type 1 diabetes | Q64069151 |
| | Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop | Q77628562 |
| | The burden of diabetes mellitus among US youth: prevalence estimates from the SEARCH for Diabetes in Youth Study | Q79174024 |
| | Proinsulin Secretion Is a Persistent Feature of Type 1 Diabetes | Q90366148 |
| | 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019 | Q90595498 |
| | 13. Children and Adolescents: Standards of Medical Care in Diabetes-2019 | Q90595539 |
| | Serum osteocalcin levels in overweight children | Q91516124 |
| | Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association | Q93051664 |
| P433 | issue | 1 | |
| P921 | main subject | osteocalcin | Q59250722 |
| P304 | page(s) | e00104 | |
| P577 | publication date | 2019-11-29 | |
| P1433 | published in | Endocrinology, Diabetes & Metabolism | Q127236882 |
| P1476 | title | Serum C-peptide and osteocalcin levels in children with recently diagnosed diabetes | |
| P478 | volume | 3 | |